We are live on
!
Find out more
JC
JBF Capital Portfolio holdings
AUM
$764M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$706M
AUM Growth
+$78M
(+12%)
Cap. Flow
+$32.1M
Cap. Flow
% of AUM
4.55%
Top 10 Holdings %
Top 10 Hldgs %
86%
Holding
88
New
22
Increased
4
Reduced
9
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$16.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$7.44M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$4.27M |
| 4 |
THTX
Theratechnologies
THTX
|
+$2.71M |
| 5 |
THRD
Third Harmonic Bio
THRD
|
+$1.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$5.33M |
| 2 |
Vistra
VST
|
+$4.85M |
| 3 |
ICAD
iCAD Inc
ICAD
|
+$686K |
| 4 |
VIGL
Vigil Neuroscience
VIGL
|
+$557K |
| 5 |
Inhibrx
INBX
|
+$299K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.42% |
| 2 | Technology | 17.55% |
| 3 | Consumer Discretionary | 15.45% |
| 4 | Communication Services | 7.98% |
| 5 | Financials | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
GeoPark
GPRK
$772M
| $63.7K | 0.01% |
10,000
-5,000
| -33% | -$33K |
|
|
LVTX
77
DELISTED
LAVA Therapeutics
LVTX
| $37.3K | 0.01% |
+23,911
| New | +$35.7K |
|
|
THRD
78
DELISTED
Third Harmonic Bio
THRD
| $7.5K | ﹤0.01% |
+250,000
| New | +$1.36M |
|
|
AKYA
79
DELISTED
Akoya BioSciences
AKYA
| – | – |
-119,508
| Closed | -$155K |
|
80
Biohaven
BHVN
$2.4B
| – | – |
-13,150
| Closed | -$186K |
|
81
CALL
GSK
GSK
$102B
| – | – |
-200
| Closed | -$51.5K |
|
82
CALL
HP
HPQ
$28.8B
| – | – |
-200
| Closed | -$28.4K |
|
|
83
iShares Bitcoin Trust
IBIT
$63.4B
| – | – |
-87,000
| Closed | -$5.33M |
|
|
ICAD
84
DELISTED
iCAD Inc
ICAD
| – | – |
-180,000
| Closed | -$686K |
|
|
85
Inhibrx
INBX
$1.8B
| – | – |
-20,949
| Closed | -$299K |
|
|
VIGL
86
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-70,000
| Closed | -$557K |
|
|
87
Vistra
VST
$48.4B
| – | – |
-25,000
| Closed | -$4.85M |
|
|
SBT
88
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| – | – |
-32,064
| Closed | – |
|
Similar funds
UCMOK
EIM
CAAM
KLI
CT
ANRF
NI
HI
JBF Capital's Q3 2025 Portfolio in Review
As of Q3 2025, JBF Capital held 88 positions worth $706M, up 12% from $628M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
JBF Capital deployed $32.1M of net new capital in Q3 2025, opening 22 new positions and adding to 4 existing holdings. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 108,000 shares worth $3.58M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was AerCap, an estimated $175K trimmed.
- JBF Capital's largest Q3 2025 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 108,000 shares worth $3.58M.
- JBF Capital added most to Alphabet (Google) Class A in Q3 2025, an estimated $16.1M increase.
- JBF Capital's biggest Q3 2025 reduction was AerCap, cutting an estimated $175K.
- JBF Capital fully exited iShares Bitcoin Trust in Q3 2025, selling an estimated $5.33M.
- JBF Capital's ten largest holdings make up 86% of its $706M portfolio in Q3 2025.
- JBF Capital opened 22 new positions and closed 10 in Q3 2025.
- JBF Capital's portfolio value rose 12% quarter-over-quarter to $706M.
Based on JBF Capital's 13F filing for Q3 2025, filed 13 Nov 2025.